Integrated transcriptional profiling and genomic analyses reveal that ribophorin II is a promising biomarker in colorectal cancer (Zhang et al., 2015) and promotes colorectal cancer proliferation via regulating the glycosylation status of EGFR (Li et al., 2017). Here, EGFR is linked to colorectal cancer.